IGHE and hematopoietic and lymphoid cell neoplasm: After adjusting for age and sex, the adjusted odds ratio increased to 15.89 (CI 95%: 4.14-60.95).<h4>Conclusion</h4>Patients with hematological cancers have significantly lower IgE levels compared with individuals with no cancer.